TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

Similar documents
Tuberculin Skin Testing

Why need to havetb Clearance. To Control and Prevent Tuberculosis

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Fundamentals of Tuberculosis (TB)

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

TB in Corrections Phoenix, Arizona

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

LATENT TUBERCULOSIS. Robert F. Tyree, MD

LTBI: Who to Test & When to Treat

Diagnosis and Medical Management of Latent TB Infection

Community pharmacy-based tuberculosis skin testing

Core Curriculum on Tuberculosis: What the Clinician Should Know

Contracts Carla Chee, MHS May 8, 2012

FLORIDA DEPARTMENT OF JUVENILE JUSTICE DETENTION SERVICES FACILITY MEDICAL POLICIES

PEDIA MANOR POLICY AND PROCEDURE MANUAL

Peggy Leslie-Smith, RN

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Latent Tuberculosis Best Practices

What Drug Treatment Centers Can do to Prevent Tuberculosis

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

Diagnosis and Medical Case Management of Latent TB. Bryan Rock, MD April 27, 2010

Latent TB, TB and the Role of the Health Department

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast

Self-Study Modules on Tuberculosis

Primer on Tuberculosis (TB) in the United States

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Management of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

11/1/2017. Disclosures. Update In Tuberculosis, Indiana Outline/Objectives. Pathogenesis of M.tb Global/U.S. TB Burden, 2016

Tuberculosis Screening and Targeted Testing of College and University Students: Developing a Best Practice Approach:

TUBERCULOSIS CONTACT INVESTIGATION

Northwestern Polytechnic University

Contact Investigation

Latent TB Infection (LTBI) Strategies for Detection and Management

Chapter 5 Treatment for Latent Tuberculosis Infection

Screening for Tuberculosis Infection. Harlingen, TX. Linda Dooley, MD has the following disclosures to make:

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Therapy for Latent Tuberculosis Infection

Tuberculosis Populations at Risk

Approaches to LTBI Diagnosis

Replaces: 02/11/16. Formulated: 7/95 EMPLOYEE TB TESTING

Chapter 7 Tuberculosis (TB)

Tuberculosis Education for the Medical Professional

These recommendations will remain in effect until the national shortage of PPD solution has abated.

Diagnosis Latent Tuberculosis. Disclosures. Case

Tuberculosis Tools: A Clinical Update

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Management of Pediatric Tuberculosis in New Jersey

Latent TB Infection (LTBI)

Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

Student Health Requirements Master of Arts, Biomedical Sciences Program

TB Transmission, Pathogenesis & Infection Control

Conflict of Interest Disclosures:

Tuberculosis Intensive

Tuberculosis Pathogenesis

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

CUSOM Student Health Immunization Requirements

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

Tuberculosis (TB) Fundamentals for School Nurses

Diagnosis and Management of Latent TB Infection Douglas Hornick, MD September 27, 2011

Self-Study Modules on Tuberculosis

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

Contact Investigation Overview

Proposed Regs.pdf

Making the Diagnosis of Tuberculosis

All you need to know about Tuberculosis

2017/2018 Annual Volunteer Tuberculosis Notice

TB Intensive Tyler, Texas December 2-4, 2008

Advanced Concepts in Pediatric TB: Latent TB Infection

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

Tuberculosis Elimination: The Role of the Infection Preventionist

Interpretation of TST & IGRA results. Objectives

Tuberculosis & Refugees in Philadelphia

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats

Stop TB Poster (laminated copies are available from TB Control: )

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Coordinating with Public Health on Tuberculosis Testing & Treatment

CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

A Mobile Health Intervention Utilizing Community Partnership to Improve Access to Latent Tuberculosis Infection Treatment

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

Overview of Contact Investigation Guidelines

TB Prevention Who and How to Screen

TB Intensive San Antonio, Texas November 11 14, 2014

Using Interferon Gamma Release Assays for Diagnosis of TB Infection

Advanced Concepts in Pediatric Tuberculosis

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016

PRE-ENTRANCE MEDICAL RECORD PART I: GENERAL INFORMATION-

TB in Corrections Phoenix, Arizona

TB Intensive San Antonio, Texas December 1-3, 2010

TUBERCULOSIS TODAY WORLD-WIDE, UNITED STATES, TEXAS J O R D A N C O U L S O N, R. N. S N S C O O R D I N A T O R, P H E P / H S R 1

INDEX CASE INFORMATION

TB Intensive Houston, Texas October 15-17, 2013

Tuberculin Purified Protein Derivative (Mantoux) Biological Page

Wisconsin State-wide Health Requirements for Students Starting Clinical Rotations

Transcription:

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014 Catalina Navarro, BSN, RN has the following disclosures to make: No conflict of interests No relevant financial relationships with any commercial companies pertaining to this educational activity Delfina Sanchez, MA has the following disclosures to make: No conflict of interests No relevant financial relationships with any commercial companies pertaining to this educational activity 1

WELCOME TB Skin Test Practicum September 23, 2014 Catalina Navarro RN,BSN Delfina Sanchez, MA Heartland National TB Center How is TB Spread? TB is spread through the air from person to person TB bacteria are passed through the air when a person with TB disease coughs, laughs, sings or sneezes.. How TB Is Transmitted From One Person to Another Core Curriculum on Tuberculosis (2000) 2

What is the Probability that TB Will Be Transmitted? Infectiousness of person with TB Susceptibility of contact Duration of exposure Concentration of droplet nuclei in air (Environment)!Majority of contacts do not become infected! What is the difference between Active TB disease vs. TB infection? Has TB bacteria in his/her body that are alive but inactive Does not feel sick and is NOT CONTAGIOUS May become sick if the bacteria become active in his/her body Should consider treatment for LTBI to prevent active TB disease Latent TB Infection (LTBI) 3

Active TB Disease Has active TB bacteria in his/her body Feels sick and experiences symptoms such as coughing, fever, and weight loss May spread TB bacteria to others Needs treatment to cure active TB disease Potential Sites of TB Disease Mantoux Tuberculin Skin Test 4

Purpose: Targeted Skin Testing Strategy for controlling and preventing TB Identifies and treats persons with TB disease Identifies and screens contacts to TB cases Screens populations at HIGH risk for LTBI (latent) and TB disease (active) Find persons who would benefit from Treatment Screening of LOW risk persons should be replaced by targeted testing. Population at High Risk for LTBI Recent Contacts Immigrants from TB endemic countries Health care workers Persons with compromised immune systems Patients in renal dialysis units Persons using TNF alpha blockers HIGH Risk for LTBI Substance abusers (especially IVDU) Homeless Persons with inadequate health care Persons who live in institutional settings (shelters, nursing homes, correctional facilities) Migrant workers 5

Medical Risk Factors for Progression to Active TB HIV infection Diabetes mellitus Malignancy Chronic renal failure Transplant patients Malnutrition Immunosuppressive therapy History of gastrectomy or jejunoileal bypass Cer Testing Methods for LTBI Mantoux Tuberculin Skin Test Interferon Gamma Release Assays (IGRAs) QuantiFERON TB Gold in tube (QFT) T Spot TB Test the decision to test is a decision to treat 6

What do we DOCUMENT when reading the TST? Record date and time of reading and name of person reading TST Record in millimeters (mm) No reaction should be written as 00 mm Tuberculin Skin Test interpretation >5 mm is considered positive in Close contacts of infectious TB cases HIV infected persons Fibrotic changes on CXR consistent with prior TB Patients with organ transplants and/or those receiving immunosuppressed treatments Tuberculin Skin Test Interpretation >10 mm is considered positive in Immigrants from high prevalence countries VDU, known to be HIV neg. Residents/employees of high risk congregate settings Mycobacteriology lab personnel Children < 4 years of age/ children exposed to adults at high risk Persons with medical conditions that place them at high risk of progression to TB disease 7

Tuberculin Skin Test Interpretation > 15mm is considered positive in; - persons with no risk factors (If there is not risk. Why did you test?) Targeted skin testing programs should only be conducted among high-risk groups What Do We Do with a Negative TST Result? Provide Documentation of result No further evaluation necessary What Do We Do with a Positive TST Result? Evaluate Further Rule Out TB Disease CXR TB Symptom Screen/ Assessment MD Evaluation Sputum Collection If disease is ruled out, consider for LTBI treatment If patient not willing or able to take treatment, educate on TB signs and symptoms 8

FAQ After TB has been transmitted, how long does it take for the body s immune system to be able to react to tuberculin? A. 48-72 hours B. 7-10 days C. 2-8 weeks D. 6 months or more FAQ What do we do if client returns after 72 hours? If TST is positive measure and record induration in millmeters If TST is read as negative, repeat TST at this time FAQ Can Infants Be Tested? YES - Infants may not react to a TST before 6 months of age, but should be tested if there is risk of exposure 9

FAQ Can a person with a previous positive TST be retested? YES Retesting is not necessary if the previous result was documented Repeated skin tests do not sensitize or make persons allergic to tuberculin FAQ How soon may I repeat a TST? May be repeated right away if initial placement was incorrect If the patient fails to return within 72 hours of placement, a repeat TST is necessary as soon as possible FAQ Can pregnant women be tested? YES No risk to mother or fetus. Pregnancy is often a good time to screen and test women who are at risk of TB 10

FAQ Can HCW s read their own TST? NO HCW s should NEVER be allowed to read their own TST Experience has shown that HCW s do not measure their own TST results reliably FAQ Do Vaccinations interfere with TST results? Yes, may cause false (-) reactions For persons scheduled to receive TST and live virus vaccines, the testing should be done either on the same day as vaccination or at least 1 month after vaccination to minimize potential of false (-) References Targeted Tuberculin Testing and Treatment of LTBI; MMWR June 9, 2000/Vol.49/No. RR-6 Guidelines for the Diagnosis of LTBI in the 21 st Century; NJ Medical School Global Tuberculosis Institute,2 nd edition June,2002 Controlling TB in the US; MMWR November 4,2005/Vol.54/No.RR-12 Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis; MMWR December 16, 2005/Vol. 54/ No. RR-15 11

Practicum Break into Groups Placing TST on each other Reading TST mannequins Hispanic Asian White Black Case scenarios 12

Hispanic 1. 6 MM 2. 13 MM 3. 17 MM 4. 00 MM 5. 00 MM Asian 1. 7 MM 2. 14 MM 3. 17 MM 4. 00 MM 5. 00 MM White 1. 6 MM 2. 13 MM 3. 19 MM 4. 00 MM 5. 00 MM Black 1. 12 MM 2. 30 MM 3. 7 MM 4. 20 MM 5. 00 MM 13